What is Gyre Therapeutics, Inc.'s price / earnings?

Gyre Therapeutics, Inc. (GYRE) reported price / earnings of 100.4× in Q3 2025.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Gyre Therapeutics, Inc. GYRE Price / earnings

Price / earnings at other companies

Eli LillyLLY

32.5×-34.3×

Theravance BiopharmaTBPH

7.3×—

Rigel PharmaceuticalsRIGL

1.4×-7.3×

Zevra Therapeutics, Inc.ZVRA

4.4×—

Innoviva, Inc.INVA

3.4×—

Royalty PharmaRPRX

24.8×+12.5×

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Calculated from Gyre Therapeutics, Inc.’s reported figures.

market cap/net income=100.4×

Based on the most recent quarter.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed November 7, 2025, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s price / earnings?: Gyre Therapeutics, Inc. (GYRE) reported price / earnings of 100.4× in Q3 2025.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.